GENEDRIVE PLC
GDR | IL
Overview
Corporate Details
- ISIN(s):
- GB00B1VKB244 (+2 more)
- LEI:
- 213800ZYODIRZ87Y4K14
- Country:
- United Kingdom
- Address:
- THE INCUBATOR BUILDING, M13 9XX MANCHESTER
- Website:
- https://genedriveplc.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, low-cost, point-of-care pharmacogenetic testing platform. The company's Genedrive® System is designed for use in time-critical healthcare settings to diagnose genetic variants at the patient's bedside. This technology enables clinicians to personalize medicine, making treatments safer and more effective. Its flagship products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The company focuses on empowering clinicians in emergency healthcare to improve patient outcomes through rapid, actionable genetic insights.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for GENEDRIVE PLC.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-21 08:00 |
Regulatory News Service
Scotland’s Public Health Minister visit
|
English | 16.8 KB | |
| 2025-08-14 11:35 |
Regulatory News Service
Comment re: Share Price Movement
|
English | 13.2 KB | |
| 2025-08-11 08:00 |
Regulatory News Service
Trading update
|
English | 17.3 KB | |
| 2025-05-30 08:00 |
Remuneration Information
Block Listing Returns
|
English | 24.6 KB | |
| 2025-05-30 08:00 |
Regulatory News Service
CE-certification
|
English | 14.9 KB | |
| 2025-05-02 14:30 |
Regulatory News Service
CYP2C19 ID Kit CE-IVD certification update
|
English | 11.0 KB | |
| 2025-03-27 16:30 |
Share Issue/Capital Change
RetailBook Offer
|
English | 38.5 KB | |
| 2025-03-27 16:29 |
Earnings Release
Half-year Report
|
English | 237.8 KB | |
| 2025-03-27 16:28 |
Share Issue/Capital Change
Equity Fundraise
|
English | 19.2 KB | |
| 2025-03-17 12:04 |
Legal Proceedings Report
Scottish Government testing programme investment
|
English | 19.9 KB | |
| 2025-03-14 08:00 |
Regulatory News Service
CYP2C19-ID Kit adopted for routine clinical use
|
English | 15.0 KB | |
| 2024-12-30 12:54 |
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
|
English | 24.2 KB | |
| 2024-12-27 08:00 |
Regulatory News Service
Genedrive® CYP2C19-ID Kit performance published
|
English | 19.3 KB | |
| 2024-12-20 13:16 |
Remuneration Information
Grant of Options
|
English | 31.8 KB | |
| 2024-12-20 13:12 |
Director's Dealing
Director/PDMR Shareholding
|
English | 26.1 KB |
Automate Your Workflow. Get a real-time feed of all GENEDRIVE PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for GENEDRIVE PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
